Showing results (31-40 of 371) with videos related to

Sort By:
Pageof 38
Thrombosis and Haemostasis|February 28, 1984
Dysfunctional plasminogen in full term newborn--study of active site of plasminA Benavent, A Estellés, J Aznar, et al.
Human Reproduction (Oxford, England)|July 2, 2003
Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosisJ Gilabert-Estellés, A Estellés, J Gilabert, et al.
Thrombosis and Haemostasis|May 29, 1999
Lipoprotein(a) levels and isoforms and fibrinolytic activity in postmenopause--influence of hormone replacement therapyA Estellés, A Cano, C Falcó, et al.
Thrombosis Research|June 1, 1992
Activated protein C: alpha 1-antitrypsin (APC: alpha 1 AT) complex as a marker for in vitro diagnosis of prethrombotic statesF España, J Gilabert, V Vicente, et al.
Thrombosis and Haemostasis|June 28, 1990
Contribution of platelets to increased plasminogen activator inhibitor type 1 in severe preeclampsiaJ Gilabert, A Estellés, J Aznar, et al.
Haemostasis|July 1, 1994
Alterations in fibrinolytic and protein C pathways in gynaecological surgery: low molecular weight heparin prophylaxisA Estellés, J Gilabert, F España, et al.
American Journal of Obstetrics and Gynecology|December 1, 1995
The effect of estrogen replacement therapy with or without progestogen on the fibrinolytic system and coagulation inhibitors in postmenopausal statusJ Gilabert, A Estellés, A Cano, et al.
Haematologica|January 9, 2001
Fibrinolysis and lipoprotein(a) in women with coronary artery disease. Influence of hormone replacement therapyC Falcó, G Tormo, A Estellés, et al.
Thrombosis and Haemostasis|May 15, 1998
Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsiaA Estellés, J Gilabert, S Grancha, et al.
The American Journal of Pathology|October 1, 1996
Abnormal expression of plasminogen activator inhibitors in patients with gestational trophoblastic diseaseA Estellés, S Grancha, J Gilabert, et al.
Pageof 38